In utero/peripartum antiretroviral therapy exposure and mental health outcomes at 8-18 years old: A longitudinal comparative study of children with perinatally acquired HIV, children perinatally HIV exposed but uninfected, and children unexposed uninfected from Uganda.

Journal: Research in nursing & health

Volume: 47

Issue: 2

Year of Publication: 2024

Affiliated Institutions:  Department of Psychiatry, University of Washington, Seattle, Washington, USA. Department of Psychiatry, Michigan State University, East Lansing, Michigan, USA. Public Health and Environment, Kampala Capital City Authority, Kampala, Uganda. Departments of Psychiatry, Neurology, Psychology, and School of Nursing, University of Michigan, Ann Arbor, Michigan, USA.

Abstract summary 

In utero/peripartum antiretroviral therapy (IPA) exposure type was examined in relationship to mental health symptoms among 577 children with perinatally acquired HIV (CPHIV), children perinatally HIV exposed but uninfected (CHEU), and children HIV unexposed uninfected (CHUU). IPA exposure was categorized for CPHIV and CHEU as none, single-dose nevirapine with or without zidovudine (sdNVP±AZT), sdNVP+AZT+lamivudine (3TC), or combination antiretroviral therapy (cART). Anxiety and depressive symptoms were reported at baseline, 6-, and 12-month follow-up per behavioral assessment system for children. Multivariable linear mixed models were used to estimate differences (b) with 95% confidence intervals (95% CI) for IPA exposure types versus CHEU without IPA exposure. Depressive and anxiety symptoms were lower in CHUU relative to CHEU and CPHIV but did not differ between CPHIV and CHEU. CHEU with sdNVP±AZT exposure had greater anxiety (b = 0.51, 95% CI: [0.06, 0.96]) and depressive symptoms (b = 0.48, 95% CI: [0.07, 0.89]) than CHEU without IPA exposure. CHEU with sdNVP+AZT+3TC exposure had higher anxiety (b = 0.0.45, 95% CI: [0.03, 0.86]) and depressive symptoms (b = 0.72, 95% CI: [0.27, 1.17]) versus CHEU without IPA exposure. Depressive and anxiety symptoms were not different for CHEU and CPHIV exposed to cART (b = 0.12-0.60, 95% CI: [-0.41, 1.30]) and CHEU and CHUU (b = -0.04 to 0.08, 95% CI: [-0.24, 0.29]) without IPA exposure. Among CHEU, peripartum sdNVP±AZT and sdNVP+AZT+3TC but not cART compared to no IPA exposure was associated with clinically important elevations in anxiety and depressive symptoms. Monitoring of mental health trajectory of HIV-affected children considering IPA is needed to inform mental health interventions. Patient Contribution: Caregivers and their dependents provided consent for participation and collaborated with study team to identify mutually convenient times for protocol implementation.

Authors & Co-authors:  Coventry Audrey A Sikorskii Alla A Zalwango Sarah K SK Familiar-Lopez Itziar I Cardino Vanessa N VN Giordani Bruno B Ezeamama Amara E AE

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Abubakar, A., Van de Vijver, F. J. R., Hassan, A. S., Fischer, R., Nyongesa, M. K., Kabunda, B., Berkley, J. A., Stein, A., & Newton, C. R. (2017). Cumulative psychosocial risk is a salient predictor of depressive symptoms among vertically HIV‐infected and HIV‐affected adolescents at the Kenyan coast. Annals of Global Health, 83(5–6), 743–752. https://doi.org/10.1016/j.aogh.2017.10.024
Authors :  7
Identifiers
Doi : 10.1002/nur.22359
SSN : 1098-240X
Study Population
Male,Female
Mesh Terms
Child
Other Terms
antiretroviral therapy exposure;anxiety;children;depression;perinatal HIV status
Study Design
Longitudinal Study,Cross Sectional Study
Study Approach
Mixed Methods
Country of Study
Uganda
Publication Country
United States